The HIV in Women and Underserved Populations Core is co-directed by Drs. Susan Cu-Uvin and Timothy P. Flanigan. Women and vulnerable populations continue to be at risk for HIV and to suffer the consequences of the epidemic with a distinct set of challenges. The Core has a broad range of expertise in research as well as clinical experience in working with women and underserved populations. It has the capability and vision to outline the pressing issues that face the CFAR and the community which can lead to innovative translational research relevant to women and underserved populations. The specific goals of the HIV in Women and Underserved Population Core are to 1) to provide mentoring and expertise/consultation relevant to HIV in women and underserved populations to the CFAR community;2) to provide essential services to CFAR investigators such as training in specific skill sets and gynecologic services necessary to carry out projects involving HIV infected women and hard to reach populations;3) to provide leadership in research and educational activities related to HIV in women and underserved populations within the CFAR and its community;with CFAR-CFAR collaborations;with NIH;with HIV Networks;and with our international partners. Core services include: a)Mentoring and support of students, postdocs, junior investigators with a focus on HIV and women and underserved populations, b) Expertise in protocol design, assessment, recruitment, enrollment, follow up of women and underserved populations, c) Particular expertise has been developed in correctional community interventions to improve adherence to antiretroviral therapy and retention in care among men and women leaving correctional settings, d) Study design, trouble shooting and workshops on clinical research in HIV within corrections has been a focus of the core, e) Study cohort availability, f) In collaboration with the Virology Core, specimen/repository access (cervicovaginal lavage, supernatant, pellets, plasma), g) Gynecologic specimen collection training and STD diagnosis and h) Colposcopy and biopsy for women's related studies (HPV vaccines, microbicides). For the past 4 years, the Core has served 60 investigators resulting in 30 grants and 309 publications involving Core faculty and users.

Public Health Relevance

A significant amount of HIV research related to women and underserved populations require specific skill sets and approaches, a training that is not readily available to many investigators. Examples are gynecologic examinations, STI diagnosis, and collection of specimen, implementation of HIV testing in underserved populations and community and corrections based interventions. The Core not only provides scientific leadership in this field of study but provides mentoring and training to achieve these scientific goals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI042853-15
Application #
8292688
Study Section
Special Emphasis Panel (ZAI1-RRS-A (J1))
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
15
Fiscal Year
2012
Total Cost
$454,151
Indirect Cost
$64,306
Name
Miriam Hospital
Department
Type
DUNS #
063902704
City
Providence
State
RI
Country
United States
Zip Code
02906
Murphy, Matthew; Berns, Abby L; Bandyopadhyay, Utpala et al. (2018) Varicella in the prison setting: A report of three outbreaks in Rhode Island and a review of the literature. Vaccine 36:5651-5656
Sam, Soya S; Caliendo, Angela M; Ingersoll, Jessica et al. (2018) Evaluation of Performance Characteristics of Panther Fusion Assays for Detection of Respiratory Viruses from Nasopharyngeal and Lower Respiratory Tract Specimens. J Clin Microbiol 56:
Peloquin, Charles A; Phillips, Patrick P J; Mitnick, Carole D et al. (2018) Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis. Antimicrob Agents Chemother 62:
Linas, Benjamin P; Nolen, Shayla (2018) A Guide to the Economics of Hepatitis C Virus Cure in 2017. Infect Dis Clin North Am 32:447-459
Carroll, Jennifer J; Rich, Josiah D; Green, Traci C (2018) The More Things Change: Buprenorphine/naloxone Diversion Continues While Treatment Remains Inaccessible. J Addict Med 12:459-465
Coleman, Sharon M; Gnatienko, Natalia; Lloyd-Travaglini, Christine A et al. (2018) False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts. HIV Clin Trials 19:15-22
Sherman, Kenneth E; Rouster, Susan D; Kong, Ling X et al. (2018) Zika Virus Exposure in an HIV-Infected Cohort in Ghana. J Acquir Immune Defic Syndr 78:e35-e38
N'Guessan, Kombo F; Boyce, Ceejay; Kwara, Awewura et al. (2018) Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Virus Genes 54:361-367
Freiman, J Morgan; Jacobson, Karen R; Muyindike, Winnie R et al. (2018) Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis. J Acquir Immune Defic Syndr 77:405-412
Chan, Philip A; Crowley, Christina; Rose, Jennifer S et al. (2018) A Network Analysis of Sexually Transmitted Diseases and Online Hookup Sites Among Men Who Have Sex With Men. Sex Transm Dis 45:462-468

Showing the most recent 10 out of 806 publications